Outlook Therapeutics, Inc. (OTLK) Operating income 2016–2025
Outlook Therapeutics, Inc. (OTLK) annual operating income history from SEC filings — each fiscal year as reported.
-$67.1MFY2025 · since FY2016: -$51.3M → -$67.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$67.1M | +6.5% |
| FY2024 | -$71.7M | -35.0% |
| FY2023 | -$53.1M | +15.8% |
| FY2022 | -$63.1M | -21.9% |
| FY2021 | -$51.7M | -40.4% |
| FY2020 | -$36.8M | -1.5% |
| FY2019 | -$36.3M | -22.4% |
| FY2018 | -$29.6M | +17.4% |
| FY2017 | -$35.9M | +30.1% |
| FY2016 | -$51.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice